Metal dyshomeostasis and oxidative stress in Alzheimer's disease

Neurochemistry International

Volumn 62, Issue 5, 2013, Pages 540-555

  Greenough, Mark A ^a   Camakaris, James ^a   Bush, Ashley I ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Alzheimer's disease; Amyloid; Copper; Homeostasis; Iron; Neurodegeneration; Oxidative stress; Zinc

Indexed keywords

8 QUINOLINOL; ADENOSINE TRIPHOSPHATE; ADVANCED GLYCATION END PRODUCT; CLIOQUINOL; COPPER ION; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GAMMA SECRETASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HOMOCYSTEINE; HYDROGEN PEROXIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; MALONALDEHYDE; MENKES PROTEIN; METAL; METALLOTHIONEIN I; METALLOTHIONEIN II; METALLOTHIONEIN III; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PBT 2; PRESENILIN 1; PRESENILIN 2; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZINC ION;

ALZHEIMER DISEASE; AMINO ACID SUBSTITUTION; BINDING AFFINITY; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID; COVALENT BOND; DISEASE COURSE; GENETIC TRANSCRIPTION; HIPPOCAMPUS; HUMAN; IMMUNOHISTOCHEMISTRY; IRON RESPONSIVE ELEMENT; LIPID PEROXIDATION; METABOLIC DISORDER; METAL BINDING; METAL DYSHOMEOSTASIS; MITOCHONDRION; NEUROBLASTOMA; NEUROTOXICITY; NITRATION; NITROSATIVE STRESS; NITROSYLATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; OXIDATIVE STRESS; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; RAMAN SPECTROMETRY; RESPIRATORY CHAIN; REVIEW; SIGNAL TRANSDUCTION; X RAY FLUORESCENCE;

ALZHEIMER DISEASE; HOMEOSTASIS; HUMANS; METALS; NITRIC OXIDE; OXIDATIVE STRESS;

EID: 84875697145     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2012.08.014     Document Type: Review

References (297)

1. K.M. Acevedo, Y.H. Hung, A.H. Dalziel, Q.X. Li, K. Laughton, K. Wikhe, A. Rembach, B. Roberts, C.L. Masters, A.I. Bush, and J. Camakaris Copper promotes the trafficking of the amyloid precursor protein J. Biol. Chem. 286 2011 8252 8262
2. J.D. Adams Jr., L.K. Klaidman, I.N. Odunze, H.C. Shen, and C.A. Miller Alzheimer's and Parkinson's disease. Brain levels of glutathione, glutathione disulfide, and vitamin E Mol. Chem. Neuropathol. 14 1991 213 226
3. P.A. Adlard, L. Bica, A.R. White, M. Nurjono, G. Filiz, P.J. Crouch, P.S. Donnelly, R. Cappai, D.I. Finkelstein, and A.I. Bush Metal ionophore treatment restores dendritic spine density and synaptic protein levels in a mouse model of Alzheimer's disease PLoS ONE 6 2011 e17669
4. P.A. Adlard, R.A. Cherny, D.I. Finkelstein, E. Gautier, E. Robb, M. Cortes, I. Volitakis, X. Liu, J.P. Smith, K. Perez, K. Laughton, Q.X. Li, S.A. Charman, J.A. Nicolazzo, S. Wilkins, K. Deleva, T. Lynch, G. Kok, C.W. Ritchie, R.E. Tanzi, R. Cappai, C.L. Masters, K.J. Barnham, and A.I. Bush Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta Neuron 59 2008 43 55
5. P.A. Adlard, J.M. Parncutt, D.I. Finkelstein, and A.I. Bush Cognitive loss in zinc transporter-3 knock-out mice. a phenocopy for the synaptic and memory deficits of Alzheimer's disease? J. Neurosci. 30 2010 1631 1636
6. P.A. Adlard, A.K. West, and J.C. Vickers Increased density of metallothionein I/II-immunopositive cortical glial cells in the early stages of Alzheimer's disease Neurobiol. Dis. 5 1998 349 356
7. M.Y. Aksenov, and W.R. Markesbery Changes in thiol content and expression of glutathione redox system genes in the hippocampus and cerebellum in Alzheimer's disease Neurosci. Lett. 302 2001 141 145
8. F.E. Ali, F. Separovic, C.J. Barrow, R.A. Cherny, F. Fraser, A.I. Bush, C.L. Masters, and K.J. Barnham Methionine regulates copper/hydrogen peroxide oxidation products of Abeta J. Pept. Sci. 11 2005 353 360
9. M. Anantharaman, J. Tangpong, J.N. Keller, M.P. Murphy, W.R. Markesbery, K.K. Kiningham, and D.K. St Clair Beta-amyloid mediated nitration of manganese superoxide dismutase: implication for oxidative stress in a APPNLH/NLH X PS-1P264L/P264L double knock-in mouse model of Alzheimer's disease Am. J. Pathol. 168 2006 1608 1618
10. G.K. Andrews Regulation and function of Zip4, the acrodermatitis enteropathica gene Biochem. Soc. Trans. 36 2008 1242 1246
11. B. Angeletti, K.J. Waldron, K.B. Freeman, H. Bawagan, I. Hussain, C.C. Miller, K.F. Lau, M.E. Tennant, C. Dennison, N.J. Robinson, and C. Dingwall BACE1 cytoplasmic domain interacts with the copper chaperone for superoxide dismutase-1 and binds copper J. Biol. Chem. 280 2005 17930 17937
12. K. Aoyama, K. Matsubara, Y. Fujikawa, Y. Nagahiro, K. Shimizu, N. Umegae, N. Hayase, H. Shiono, and S. Kobayashi Nitration of manganese superoxide dismutase in cerebrospinal fluids is a marker for peroxynitrite-mediated oxidative stress in neurodegenerative diseases Ann. Neurol. 47 2000 524 527
13. S. Ariogul, M. Cankurtaran, N. Dagli, M. Khalil, and B. Yavuz Vitamin B12, folate, homocysteine and dementia: are they really related? Arch. Gerontol. Geriatr. 40 2005 139 146
14. A.D. Armendariz, M. Gonzalez, A.V. Loguinov, and C.D. Vulpe Gene expression profiling in chronic copper overload reveals upregulation of Prnp and App Physiol. Genomics 20 2004 45 54
15. C.S. Atwood, X. Huang, A. Khatri, R.C. Scarpa, Y.S. Kim, R.D. Moir, R.E. Tanzi, A.E. Roher, and A.I. Bush Copper catalyzed oxidation of Alzheimer Abeta Cell Mol. Biol. (Noisy-le-grand) 46 2000 777 783
16. C.S. Atwood, R.D. Moir, X. Huang, R.C. Scarpa, N.M. Bacarra, D.M. Romano, M.A. Hartshorn, R.E. Tanzi, and A.I. Bush Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis J. Biol. Chem. 273 1998 12817 12826
17. C.S. Atwood, G. Perry, H. Zeng, Y. Kato, W.D. Jones, K.Q. Ling, X. Huang, R.D. Moir, D. Wang, L.M. Sayre, M.A. Smith, S.G. Chen, and A.I. Bush Copper mediates dityrosine cross-linking of Alzheimer's amyloid-beta Biochemistry 43 2004 560 568
18. C.S. Atwood, R.C. Scarpa, X. Huang, R.D. Moir, W.D. Jones, D.P. Fairlie, R.E. Tanzi, and A.I. Bush Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42 J. Neurochem. 75 2000 1219 1233
19. J.E. Baggott, and T. Tamura Iron-dependent formation of homocysteine from methionine and other thioethers Eur. J. Clin. Nutr. 61 2007 1359 1363
20. I. Baldeiras, I. Santana, M.T. Proenca, M.H. Garrucho, R. Pascoal, A. Rodrigues, D. Duro, and C.R. Oliveira Peripheral oxidative damage in mild cognitive impairment and mild Alzheimer's disease J. Alzheimers Dis. 15 2008 117 128
21. N. Ballatori, S.M. Krance, S. Notenboom, S. Shi, K. Tieu, and C.L. Hammond Glutathione dysregulation and the etiology and progression of human diseases Biol. Chem. 390 2009 191 214
22. S.J. Baloyannis Mitochondria are related to synaptic pathology in Alzheimer's disease Int. J. Alzheimers Dis. 2011 2011 305395
23. S. Barghorn, V. Nimmrich, A. Striebinger, C. Krantz, P. Keller, B. Janson, M. Bahr, M. Schmidt, R.S. Bitner, J. Harlan, E. Barlow, U. Ebert, and H. Hillen Globular amyloid beta-peptide oligomer-a homogenous and stable neuropathological protein in Alzheimer's disease J. Neurochem. 95 2005 834 847
24. K.J. Barnham, F. Haeffner, G.D. Ciccotosto, C.C. Curtain, D. Tew, C. Mavros, K. Beyreuther, D. Carrington, C.L. Masters, R.A. Cherny, R. Cappai, and A.I. Bush Tyrosine gated electron transfer is key to the toxic mechanism of Alzheimer's disease beta-amyloid FASEB J. 18 2004 1427 1429
25. K.J. Barnham, W.J. McKinstry, G. Multhaup, D. Galatis, C.J. Morton, C.C. Curtain, N.A. Williamson, A.R. White, M.G. Hinds, R.S. Norton, K. Beyreuther, C.L. Masters, M.W. Parker, and R. Cappai Structure of the Alzheimer's disease amyloid precursor protein copper binding domain. A regulator of neuronal copper homeostasis J. Biol. Chem. 278 2003 17401 17407
26. A.E. Barry, I. Klyubin, J.M. Mc Donald, A.J. Mably, M.A. Farrell, M. Scott, D.M. Walsh, and M.J. Rowan Alzheimer's disease brain-derived amyloid-beta-mediated inhibition of LTP in vivo is prevented by immunotargeting cellular prion protein J. Neurosci. 31 2011 7259 7263
27. M.J. Barsoum, H. Yuan, A.A. Gerencser, G. Liot, Y. Kushnareva, S. Graber, I. Kovacs, W.D. Lee, J. Waggoner, J. Cui, A.D. White, B. Bossy, J.C. Martinou, R.J. Youle, S.A. Lipton, M.H. Ellisman, G.A. Perkins, and E. Bossy-Wetzel Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons EMBO J. 25 2006 3900 3911
28. G. Bartzokis, J. Mintz, D. Sultzer, P. Marx, J.S. Herzberg, C.K. Phelan, and S.R. Marder In vivo MR evaluation of age-related increases in brain iron AJNR Am. J. Neuroradiol. 15 1994 1129 1138
29. G. Bartzokis, D. Sultzer, J. Mintz, L.E. Holt, P. Marx, C.K. Phelan, and S.R. Marder In vivo evaluation of brain iron in Alzheimer's disease and normal subjects using MRI Biol. Psychiatry 35 1994 480 487
30. G. Bartzokis, and T.A. Tishler MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease Cell Mol. Biol. (Noisy-le-grand) 46 2000 821 833
31. H. Basun, L.G. Forssell, L. Wetterberg, and B. Winblad Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer's disease J. Neural. Trans. Park Dis. Dement. Sect. 3 1991 231 258
32. L. Baum, I.H. Chan, S.K. Cheung, W.B. Goggins, V. Mok, L. Lam, V. Leung, E. Hui, C. Ng, J. Woo, H.F. Chiu, B.C. Zee, W. Cheng, M.H. Chan, S. Szeto, V. Lui, J. Tsoh, A.I. Bush, C.W. Lam, and T. Kwok Serum zinc is decreased in Alzheimer's disease and serum arsenic correlates positively with cognitive ability Biometals 23 2010 173 179
33. M.F. Beal Mitochondria take center stage in aging and neurodegeneration Ann. Neurol. 58 2005 495 505
34. S.G. Bell, and B.L. Vallee The metallothionein/thionein system: an oxidoreductive metabolic zinc link ChemBioChem 10 2009 55 62
35. S.A. Bellingham, G.D. Ciccotosto, B.E. Needham, L.R. Fodero, A.R. White, C.L. Masters, R. Cappai, and J. Camakaris Gene knockout of amyloid precursor protein and amyloid precursor-like protein-2 increases cellular copper levels in primary mouse cortical neurons and embryonic fibroblasts J. Neurochem. 91 2004 423 428
36. S.A. Bellingham, D.K. Lahiri, B. Maloney, S. La Fontaine, G. Multhaup, and J. Camakaris Copper depletion down-regulates expression of the Alzheimer's disease amyloid-beta precursor protein gene J. Biol. Chem. 279 2004 20378 20386
37. I. Benilova, E. Karran, and B. De Strooper The toxic Abeta oligomer and Alzheimer's disease: an emperor in need of clothes Nat. Neurosci. 15 2012 349 357
38. J. Bereiter-Hahn, and M. Voth Dynamics of mitochondria in living cells: shape changes, dislocations, fusion, and fission of mitochondria Microsc. Res. Tech. 27 1994 198 219
39. P. Bermejo, S. Martin-Aragon, J. Benedi, C. Susin, E. Felici, P. Gil, J.M. Ribera, and A.M. Villar Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer's disease from mild cognitive impairment Free Radic. Res. 42 2008 162 170
40. S.L. Bernstein, N.F. Dupuis, N.D. Lazo, T. Wyttenbach, M.M. Condron, G. Bitan, D.B. Teplow, J.E. Shea, B.T. Ruotolo, C.V. Robinson, and M.T. Bowers Amyloid-beta protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease Nat. Chem. 1 2009 326 331
41. M.J. Berridge The endoplasmic reticulum: a multifunctional signaling organelle Cell Calcium 32 2002 235 249
42. L. Bertram, C.M. Lill, and R.E. Tanzi The genetics of Alzheimer disease: back to the future Neuron 68 2010 270 281
43. N. Beyer, D.T. Coulson, S. Heggarty, R. Ravid, G.B. Irvine, J. Hellemans, and J.A. Johnston ZnT3 mRNA levels are reduced in Alzheimer's disease post-mortem brain Mol. Neurodegener 4 2009 53
44. D.J. Bobilya, N.A. Gauthier, S. Karki, B.J. Olley, and W.K. Thomas Longitudinal changes in zinc transport kinetics, metallothionein and zinc transporter expression in a blood-brain barrier model in response to a moderately excessive zinc environment J. Nutr. Biochem. 19 2008 129 137
45. D. Boehning, and S.H. Snyder Novel neural modulators Annu. Rev. Neurosci. 26 2003 105 131
46. T. Borchardt, J. Camakaris, R. Cappai, C.L. Masters, K. Beyreuther, and G. Multhaup Copper inhibits beta-amyloid production and stimulates the non-amyloidogenic pathway of amyloid-precursor-protein secretion Biochem. J. 344 Pt 2 1999 461 467
47. E. Bossy-Wetzel, M.J. Barsoum, A. Godzik, R. Schwarzenbacher, and S.A. Lipton Mitochondrial fission in apoptosis, neurodegeneration and aging Curr. Opin. Cell Biol. 15 2003 706 716
48. H. Braak, and E. Braak Neurofibrillary changes confined to the entorhinal region and an abundance of cortical amyloid in cases of presenile and senile dementia Acta Neuropathol. 80 1990 479 486
49. H. Braak, and E. Braak Neuropathological stageing of Alzheimer-related changes Acta Neuropathol. 82 1991 239 259
50. M.W. Bradbury Transport of iron in the blood-brain-cerebrospinal fluid system J. Neurochem. 69 1997 443 454
51. V.W. Bunker, L.J. Hinks, M.F. Stansfield, M.S. Lawson, and B.E. Clayton Metabolic balance studies for zinc and copper in housebound elderly people and the relationship between zinc balance and leukocyte zinc concentrations Am. J. Clin. Nutr. 46 1987 353 359
52. A.I. Bush Drug development based on the metals hypothesis of Alzheimer's disease J. Alzheimers Dis. 15 2008 223 240
53. A.I. Bush The Metal Theory of Alzheimer's Disease J Alzheimers Dis. 30 2012 1 5
54. A.I. Bush, G. Multhaup, R.D. Moir, T.G. Williamson, D.H. Small, B. Rumble, P. Pollwein, K. Beyreuther, and C.L. Masters A novel zinc(II) binding site modulates the function of the beta A4 amyloid protein precursor of Alzheimer's disease J. Biol. Chem. 268 1993 16109 16112
55. A.I. Bush, W.H. Pettingell Jr., M. de Paradis, R.E. Tanzi, and W. Wasco The amyloid beta-protein precursor and its mammalian homologues. Evidence for a zinc-modulated heparin-binding superfamily J. Biol. Chem. 269 1994 26618 26621
56. A.I. Bush, W.H. Pettingell Jr., M.D. Paradis, and R.E. Tanzi Modulation of A beta adhesiveness and secretase site cleavage by zinc J. Biol. Chem. 269 1994 12152 12158
57. A.I. Bush, W.H. Pettingell, G. Multhaup, M. dParadis, J.P. Vonsattel, J.F. Gusella, K. Beyreuther, C.L. Masters, and R.E. Tanzi Rapid induction of Alzheimer A beta amyloid formation by zinc Science 265 1994 1464 1467
58. A.I. Bush, and R.E. Tanzi Therapeutics for Alzheimer's disease based on the metal hypothesis Neurotherapeutics 5 2008 421 432
59. D.A. Butterfield, H.F. Poon, D. St Clair, J.N. Keller, W.M. Pierce, J.B. Klein, and W.R. Markesbery Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease Neurobiol. Dis. 22 2006 223 232
60. D.A. Butterfield, T. Reed, and R. Sultana Roles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer's disease Free Radic Res 45 2011 59 72
61. A. Casado, M. Encarnacion Lopez-Fernandez, M. Concepcion Casado, and R. de La Torre Lipid peroxidation and antioxidant enzyme activities in vascular and Alzheimer dementias Neurochem. Res. 33 2008 450 458
62. C. Caspersen, N. Wang, J. Yao, A. Sosunov, X. Chen, J.W. Lustbader, H.W. Xu, D. Stern, G. McKhann, and S.D. Yan Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease FASEB J. 19 2005 2040 2041
63. A. Castegna, V. Thongboonkerd, J.B. Klein, B. Lynn, W.R. Markesbery, and D.A. Butterfield Proteomic identification of nitrated proteins in Alzheimer's disease brain J. Neurochem. 85 2003 1394 1401
64. A.M. Cataldo, C.M. Peterhoff, J.C. Troncoso, T. Gomez-Isla, B.T. Hyman, and R.A. Nixon Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations Am. J. Pathol. 157 2000 277 286
65. M.A. Cater, K.T. McInnes, Q.X. Li, I. Volitakis, S. La Fontaine, J.F. Mercer, and A.I. Bush Intracellular copper deficiency increases amyloid-beta secretion by diverse mechanisms Biochem. J. 412 2008 141 152
66. Cerqueira, F.M., Kowaltowski, A.J., 2012. Mitochondrial metabolism in aging: Effect of dietary interventions. Ageing Res. Rev. in press, http://dx.doi.org/10.1016/j.arr.2012.03.009.
67. R.A. Cherny, C.S. Atwood, M.E. Xilinas, D.N. Gray, W.D. Jones, C.A. McLean, K.J. Barnham, I. Volitakis, F.W. Fraser, Y. Kim, X. Huang, L.E. Goldstein, R.D. Moir, J.T. Lim, K. Beyreuther, H. Zheng, R.E. Tanzi, C.L. Masters, and A.I. Bush Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice Neuron 30 2001 665 676
68. D.H. Cho, T. Nakamura, J. Fang, P. Cieplak, A. Godzik, Z. Gu, and S.A. Lipton S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury Science 324 2009 102 105
69. G.D. Ciccotosto, D. Tew, C.C. Curtain, D. Smith, D. Carrington, C.L. Masters, A.I. Bush, R.A. Cherny, R. Cappai, and K.J. Barnham Enhanced toxicity and cellular binding of a modified amyloid beta peptide with a methionine to valine substitution J. Biol. Chem. 279 2004 42528 42534
70. Cito, A., Porcelli, B., Coppola, M.G., Mangiavacchi, P., Cortelazzo, A., Terzuoli, L., 2010. Analysis of serum levels of homocysteine and oxidative stress markers in patients with Alzheimer disease. Biomed. Pharmacother. in press, http://dx.doi.org/10.1016/j.biopha.2012.09.018.
71. E.D. Ciuculescu, Y. Mekmouche, and P. Faller Metal-binding properties of the peptide APP170-188: a model of the ZnII-binding site of amyloid precursor protein (APP) Chemistry 11 2005 903 909
72. R. Clarke, A.D. Smith, K.A. Jobst, H. Refsum, L. Sutton, and P.M. Ueland Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease Arch. Neurol. 55 1998 1449 1455
73. K. Coen, and W. Annaert Presenilins: how much more than gamma-secretase?! Biochem. Soc. Trans. 38 2010 1474 1478
74. S.L. Cole, and R. Vassar The role of amyloid precursor protein processing by BACE1, the beta-secretase, in Alzheimer disease pathophysiology J. Biol. Chem. 283 2008 29621 29625
75. P.J. Crouch, S.M. Harding, A.R. White, J. Camakaris, A.I. Bush, and C.L. Masters Mechanisms of A beta mediated neurodegeneration in Alzheimer's disease Int. J. Biochem. Cell Biol. 40 2008 181 198
76. P.J. Crouch, L.W. Hung, P.A. Adlard, M. Cortes, V. Lal, G. Filiz, K.A. Perez, M. Nurjono, A. Caragounis, T. Du, K. Laughton, I. Volitakis, A.I. Bush, Q.X. Li, C.L. Masters, R. Cappai, R.A. Cherny, P.S. Donnelly, A.R. White, and K.J. Barnham Increasing Cu bioavailability inhibits Abeta oligomers and tau phosphorylation Proc. Natl. Acad. Sci. USA 106 2009 381 386
77. P.J. Crouch, M.S. Savva, L.W. Hung, P.S. Donnelly, A.I. Mot, S.J. Parker, M.A. Greenough, I. Volitakis, P.A. Adlard, R.A. Cherny, C.L. Masters, A.I. Bush, K.J. Barnham, and A.R. White The Alzheimer's therapeutic PBT2 promotes amyloid-beta degradation and GSK3 phosphorylation via a metal chaperone activity J. Neurochem. 119 2011 220 230
78. C.C. Curtain, F. Ali, I. Volitakis, R.A. Cherny, R.S. Norton, K. Beyreuther, C.J. Barrow, C.L. Masters, A.I. Bush, and K.J. Barnham Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits J. Biol. Chem. 276 2001 20466 20473
79. G.F. da Silva, V. Lykourinou, A. Angerhofer, and L.J. Ming Methionine does not reduce Cu(II)-beta-amyloid!-rectification of the roles of methionine-35 and reducing agents in metal-centered oxidation chemistry of Cu(II)-beta-amyloid Biochim. Biophys. Acta 1792 2009 49 55
80. S.O. Dahms, I. Konnig, D. Roeser, K.H. Guhrs, M.C. Mayer, D. Kaden, G. Multhaup, and M.E. Than Metal binding dictates conformation and function of the amyloid precursor protein (APP) E2 domain J. Mol. Biol. 416 2012 438 452
81. J. Danielsson, R. Pierattelli, L. Banci, and A. Graslund High-resolution NMR studies of the zinc-binding site of the Alzheimer's amyloid beta-peptide FEBS J. 274 2007 46 59
82. G. Danscher, K.B. Jensen, C.J. Frederickson, K. Kemp, A. Andreasen, S. Juhl, M. Stoltenberg, and R. Ravid Increased amount of zinc in the hippocampus and amygdala of Alzheimer's diseased brains: a proton-induced X-ray emission spectroscopic analysis of cryostat sections from autopsy material J. Neurosci. Methods 76 1997 53 59
83. P.K. Datta, and E.A. Lianos Nitric oxide induces metallothionein-I gene expression in mesangial cells Transl. Res. 148 2006 180 187
84. S. Daumas, H. Halley, and J.M. Lassalle Disruption of hippocampal CA3 network: effects on episodic-like memory processing in C57BL/6J mice Eur. J. Neurosci. 20 2004 597 600
85. I. De Domenico, D.M. Ward, M.C. di Patti, S.Y. Jeong, S. David, G. Musci, and J. Kaplan Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin EMBO J. 26 2007 2823 2831
86. A. Deshpande, H. Kawai, R. Metherate, C.G. Glabe, and J. Busciglio A role for synaptic zinc in activity-dependent Abeta oligomer formation and accumulation at excitatory synapses J. Neurosci. 29 2009 4004 4015
87. L. Devi, B.M. Prabhu, D.F. Galati, N.G. Avadhani, and H.K. Anandatheerthavarada Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction J. Neurosci. 26 2006 9057 9068
88. S.I. Dikalov, M.P. Vitek, and R.P. Mason Cupric-amyloid beta peptide complex stimulates oxidation of ascorbate and generation of hydroxyl radical Free Radic. Biol. Med. 36 2004 340 347
89. Z.C. Ding, F.Y. Ni, and Z.X. Huang Neuronal growth-inhibitory factor (metallothionein-3): structure-function relationships FEBS J. 277 2010 2912 2920
90. Doecke, J.D., Laws, S.M., Faux, N.G., Wilson, W., Burnham, S.C., Lam, C.P., Mondal, A., Bedo, J., Bush, A.I., Brown, B., De Ruyck, K., Ellis, K.A., Fowler, C., Gupta, V.B., Head, R., Macaulay, S.L., Pertile, K., Rowe, C.C., Rembach, A., Rodrigues, M., Rumble, R., Szoeke, C., Taddei, K., Taddei, T., Trounson, B., Ames, D., Masters, C.L., Martins, R.N., 2012. Blood-based protein biomarkers for diagnosis of alzheimer disease. Arch. Neurol. in press, http://dx.doi.org/10.1001/archneurol.2012.1282.
91. J. Dong, C.S. Atwood, V.E. Anderson, S.L. Siedlak, M.A. Smith, G. Perry, and P.R. Carey Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence Biochemistry 42 2003 2768 2773
92. P.S. Donnelly, A. Caragounis, T. Du, K.M. Laughton, I. Volitakis, R.A. Cherny, R.A. Sharples, A.F. Hill, Q.X. Li, C.L. Masters, K.J. Barnham, and A.R. White Selective intracellular release of copper and zinc ions from bis(thiosemicarbazonato) complexes reduces levels of Alzheimer disease amyloid-beta peptide J. Biol. Chem. 283 2008 4568 4577
93. P.M. Doraiswamy Non-cholinergic strategies for treating and preventing Alzheimer's disease CNS Drugs 16 2002 811 824
94. Duce, J.A., Ayton, S., Miller, A.A., Tsatsanis, A., Lam, L.Q., Leone, L., Corbin, J.E., Butzkueven, H., Kilpatrick, T.J., Rogers, J.T., Barnham, K.J., Finkelstein, D.I., Bush, A.I., 2012. Amine oxidase activity of beta-amyloid precursor protein modulates systemic and local catecholamine levels. Mol. Psychiatry. in press, http://dx.doi.org/10.1038/mp.2011.168.
95. J.A. Duce, A. Tsatsanis, M.A. Cater, S.A. James, E. Robb, K. Wikhe, S.L. Leong, K. Perez, T. Johanssen, M.A. Greenough, H.H. Cho, D. Galatis, R.D. Moir, C.L. Masters, C. McLean, R.E. Tanzi, R. Cappai, K.J. Barnham, G.D. Ciccotosto, J.T. Rogers, and A.I. Bush Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer's disease Cell 142 2010 857 867
96. J. Durand, G. Meloni, C. Talmard, M. Vasak, and P. Faller Zinc release of Zn(7)-metallothionein-3 induces fibrillar type amyloid-beta aggregates Metallomics 2 2010 741 744
97. A. Eckert, S. Hauptmann, I. Scherping, V. Rhein, F. Muller-Spahn, J. Gotz, and W.E. Muller Soluble beta-amyloid leads to mitochondrial defects in amyloid precursor protein and tau transgenic mice Neurodegener Dis. 5 2008 157 159
98. D.J. Eide The oxidative stress of zinc deficiency Metallomics 3 2011 1124 1129
99. I. El Ghazi, B.L. Martin, and I.M. Armitage Metallothionein-3 is a component of a multiprotein complex in the mouse brain Exp. Biol. Med. (Maywood) 231 2006 1500 1506
100. I. El Ghazi, B.L. Martin, and I.M. Armitage New proteins found interacting with brain metallothionein-3 are linked to secretion Int. J. Alzheimers Dis. 2011 2010 208634
101. M.R. Farlow NMDA receptor antagonists. A new therapeutic approach for Alzheimer's disease Geriatrics 59 2004 22 27
102. N.G. Faux, C.W. Ritchie, A. Gunn, A. Rembach, A. Tsatsanis, J. Bedo, J. Harrison, L. Lannfelt, K. Blennow, H. Zetterberg, M. Ingelsson, C.L. Masters, R.E. Tanzi, J.L. Cummings, C.M. Herd, and A.I. Bush PBT2 rapidly improves cognition in Alzheimer's disease: additional phase II analyses J. Alzheimers Dis. 20 2010 509 516
103. P.C. Ford, B.O. Fernandez, and M.D. Lim Mechanisms of reductive nitrosylation in iron and copper models relevant to biological systems Chem. Rev. 105 2005 2439 2455
104. J. Frackowiak, A. Zoltowska, and H.M. Wisniewski Non-fibrillar beta-amyloid protein is associated with smooth muscle cells of vessel walls in Alzheimer disease J. Neuropathol. Exp. Neurol. 53 1994 637 645
105. C.J. Frederickson, S.W. Suh, D. Silva, and R.B. Thompson Importance of zinc in the central nervous system: the zinc-containing neuron J. Nutr. 130 2000 1471S 1483S
106. R.E. Frederickson, C.J. Frederickson, and G. Danscher In situ binding of bouton zinc reversibly disrupts performance on a spatial memory task Behav. Brain Res. 38 1990 25 33
107. D.B. Freir, A.J. Nicoll, I. Klyubin, S. Panico, J.M. Mc Donald, E. Risse, E.A. Asante, M.A. Farrow, R.B. Sessions, H.R. Saibil, A.R. Clarke, M.J. Rowan, D.M. Walsh, and J. Collinge Interaction between prion protein and toxic amyloid beta assemblies can be therapeutically targeted at multiple sites Nat. Commun. 2 2011 336
108. A.L. Friedlich, J.Y. Lee, T. van Groen, R.A. Cherny, I. Volitakis, T.B. Cole, R.D. Palmiter, J.Y. Koh, and A.I. Bush Neuronal zinc exchange with the blood vessel wall promotes cerebral amyloid angiopathy in an animal model of Alzheimer's disease J. Neurosci. 24 2004 3453 3459
109. A. Furuta, D.L. Price, C.A. Pardo, J.C. Troncoso, Z.S. Xu, N. Taniguchi, and L.J. Martin Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus Am. J. Pathol. 146 1995 357 367
110. M. Gallucci, A. Zanardo, L. De Valentin, and A. Vianello Homocysteine in Alzheimer disease and vascular dementia Arch. Gerontol. Geriatr. Suppl. 9 2004 195 200
111. K. Ghoshal, and S.T. Jacob Regulation of metallothionein gene expression Prog. Nucleic Acid Res. Mol. Biol. 66 2001 357 384
112. G.E. Gibson, K.F. Sheu, and J.P. Blass Abnormalities of mitochondrial enzymes in Alzheimer disease J. Neural. Transm. 105 1998 855 870
113. D.A. Gimbel, H.B. Nygaard, E.E. Coffey, E.C. Gunther, J. Lauren, Z.A. Gimbel, and S.M. Strittmatter Memory impairment in transgenic Alzheimer mice requires cellular prion protein J. Neurosci. 30 2010 6367 6374
114. M.L. Giuffrida, G. Grasso, M. Ruvo, C. Pedone, A. Saporito, D. Marasco, B. Pignataro, C. Cascio, A. Copani, and E. Rizzarelli Abeta(25-35) and its C- and/or N-blocked derivatives: copper driven structural features and neurotoxicity J. Neurosci. Res. 85 2007 623 633
115. Y. Gong, L. Chang, K.L. Viola, P.N. Lacor, M.P. Lambert, C.E. Finch, G.A. Krafft, and W.L. Klein Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss Proc. Natl. Acad. Sci. USA 100 2003 10417 10422
116. E.H. Gray, K.J. De Vos, C. Dingwall, M.S. Perkinton, and C.C. Miller Deficiency of the copper chaperone for superoxide dismutase increases amyloid-beta production J. Alzheimers Dis. 21 2010 1101 1105
117. M. Greenough, L. Pase, I. Voskoboinik, M.J. Petris, A.W. O'Brien, and J. Camakaris Signals regulating trafficking of Menkes (MNK; ATP7A) copper-translocating P-type ATPase in polarized MDCK cells Am. J. Physiol. Cell Physiol. 287 2004 C1463 1471
118. M.A. Greenough, I. Volitakis, Q.X. Li, K. Laughton, G. Evin, M. Ho, A.H. Dalziel, J. Camakaris, and A.I. Bush Presenilins promote the cellular uptake of copper and zinc and maintain Cu-chaperone of sod1-dependent Cu/Zn superoxide dismutase activity J. Biol. Chem. 286 2011 9776 9786
119. M. Gu, A.D. Owen, S.E. Toffa, J.M. Cooper, D.T. Dexter, P. Jenner, C.D. Marsden, and A.H. Schapira Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases J. Neurol. Sci. 158 1998 24 29
120. Z. Gu, T. Nakamura, and S.A. Lipton Redox reactions induced by nitrosative stress mediate protein misfolding and mitochondrial dysfunction in neurodegenerative diseases Mol. Neurobiol. 41 2010 55 72
121. I. Guidi, D. Galimberti, E. Venturelli, C. Lovati, R. Del Bo, C. Fenoglio, A. Gatti, R. Dominici, S. Galbiati, R. Virgilio, S. Pomati, G.P. Comi, C. Mariani, G. Forloni, N. Bresolin, and E. Scarpini Influence of the Glu298Asp polymorphism of NOS3 on age at onset and homocysteine levels in AD patients Neurobiol. Aging 26 2005 789 794
122. F.X. Guix, T. Wahle, K. Vennekens, A. Snellinx, L. Chavez-Gutierrez, G. Ill-Raga, E. Ramos, C. Guardia-Laguarta, A. Lleo, M. Arimon, O. Berezovska, F.J. Munoz, C.G. Dotti, and B. De Strooper Modification of gamma-secretase by nitrosative stress links neuronal aging to sporadic Alzheimer's disease EMBO Mol Med. 4 2012 660 673
123. Q. Guo, L. Sebastian, B.L. Sopher, M.W. Miller, C.B. Ware, G.M. Martin, and M.P. Mattson Increased vulnerability of hippocampal neurons from presenilin-1 mutant knock-in mice to amyloid beta-peptide toxicity: central roles of superoxide production and caspase activation J. Neurochem. 72 1999 1019 1029
124. Y. Guo, K. Smith, J. Lee, D.J. Thiele, and M.J. Petris Identification of methionine-rich clusters that regulate copper-stimulated endocytosis of the human Ctr1 copper transporter J. Biol. Chem. 279 2004 17428 17433
125. J.A. Gutierrez, J. Yu, S. Rivera, and M. Wessling-Resnick Functional expression cloning and characterization of SFT, a stimulator of Fe transport J. Cell Biol. 139 1997 895 905
126. A.R. Gwon, J.S. Park, T.V. Arumugam, Y.K. Kwon, S.L. Chan, S.H. Kim, S.H. Baik, S. Yang, Y.K. Yun, Y. Choi, S. Kim, S.C. Tang, D.H. Hyun, A. Cheng, C.E. Dann 3rd, M. Bernier, J. Lee, W.R. Markesbery, M.P. Mattson, and D.G. Jo Oxidative lipid modification of nicastrin enhances amyloidogenic gamma-secretase activity in Alzheimer's disease Aging Cell. 11 2012 559 568
127. C. Ha, J. Ryu, and C.B. Park Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template Biochemistry 46 2007 6118 6125
128. F. Haeffner, D.G. Smith, K.J. Barnham, and A.I. Bush Model studies of cholesterol and ascorbate oxidation by copper complexes: relevance to Alzheimer's disease beta-amyloid metallochemistry J. Inorg. Biochem. 99 2005 2403 2422
129. Z.L. Harris, Y. Takahashi, H. Miyajima, M. Serizawa, R.T. MacGillivray, and J.D. Gitlin Aceruloplasminemia: molecular characterization of this disorder of iron metabolism Proc. Natl. Acad. Sci. USA 92 1995 2539 2543
130. K. Hensley, M.L. Maidt, Z. Yu, H. Sang, W.R. Markesbery, and R.A. Floyd Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation J. Neurosci. 18 1998 8126 8132
131. F. Hernandez, E. Gomez de Barreda, A. Fuster-Matanzo, J.J. Lucas, and J. Avila GSK3: a possible link between beta amyloid peptide and tau protein Exp. Neurol. 223 2010 322 325
132. N. Herrmann, S.A. Chau, I. Kircanski, and K.L. Lanctot Current and emerging drug treatment options for Alzheimer's disease: a systematic review Drugs. 71 2011 2031 2065
133. L. Hesse, D. Beher, C.L. Masters, and G. Multhaup The beta A4 amyloid precursor protein binding to copper FEBS Lett. 349 1994 109 116
134. J. Hidalgo, M. Penkowa, C. Espejo, E.M. Martinez-Caceres, J. Carrasco, A. Quintana, A. Molinero, S. Florit, M. Giralt, and A. Ortega-Aznar Expression of metallothionein-I, -II, and -III in Alzheimer disease and animal models of neuroinflammation Exp. Biol. Med. (Maywood) 231 2006 1450 1458
135. K. Honda, M.A. Smith, X. Zhu, D. Baus, W.C. Merrick, A.M. Tartakoff, T. Hattier, P.L. Harris, S.L. Siedlak, H. Fujioka, Q. Liu, P.I. Moreira, F.P. Miller, A. Nunomura, S. Shimohama, and G. Perry Ribosomal RNA in Alzheimer disease is oxidized by bound redox-active iron J. Biol. Chem. 280 2005 20978 20986
136. L. Hou, and M.G. Zagorski NMR reveals anomalous copper(II) binding to the amyloid Abeta peptide of Alzheimer's disease J. Am. Chem. Soc. 128 2006 9260 9261
137. W.P. Hu, G.L. Chang, S.J. Chen, and Y.M. Kuo Kinetic analysis of beta-amyloid peptide aggregation induced by metal ions based on surface plasmon resonance biosensing J. Neurosci. Methods 154 2006 190 197
138. H.C. Huang, and Z.F. Jiang Accumulated amyloid-beta peptide and hyperphosphorylated tau protein: relationship and links in Alzheimer's disease J. Alzheimers Dis. 16 2009 15 27
139. X. Huang, C.S. Atwood, M.A. Hartshorn, G. Multhaup, L.E. Goldstein, R.C. Scarpa, M.P. Cuajungco, D.N. Gray, J. Lim, R.D. Moir, R.E. Tanzi, and A.I. Bush The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction Biochemistry 38 1999 7609 7616
140. X. Huang, M.P. Cuajungco, C.S. Atwood, M.A. Hartshorn, J.D. Tyndall, G.R. Hanson, K.C. Stokes, M. Leopold, G. Multhaup, L.E. Goldstein, R.C. Scarpa, A.J. Saunders, J. Lim, R.D. Moir, C. Glabe, E.F. Bowden, C.L. Masters, D.P. Fairlie, R.E. Tanzi, and A.I. Bush Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction J. Biol. Chem. 274 1999 37111 37116
141. Y.H. Hung, E.L. Robb, I. Volitakis, M. Ho, G. Evin, Q.X. Li, J.G. Culvenor, C.L. Masters, R.A. Cherny, and A.I. Bush Paradoxical condensation of copper with elevated beta-amyloid in lipid rafts under cellular copper deficiency conditions: implications for Alzheimer disease J. Biol. Chem. 284 2009 21899 21907
142. K. Inoue, D. Branigan, and Z.G. Xiong Zinc-induced neurotoxicity mediated
143. H. Ischiropoulos, L. Zhu, J. Chen, M. Tsai, J.C. Martin, C.D. Smith, and J.S. Beckman Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase Arch. Biochem. Biophys. 298 1992 431 437
144. G.S. Jackson, I. Murray, L.L. Hosszu, N. Gibbs, J.P. Waltho, A.R. Clarke, and J. Collinge Location and properties of metal-binding sites on the human prion protein Proc. Natl. Acad. Sci. USA 98 2001 8531 8535
145. D. Jiang, L. Men, J. Wang, Y. Zhang, S. Chickenyen, Y. Wang, and F. Zhou Redox reactions of copper complexes formed with different beta-amyloid peptides and their neuropathological [correction of neuropathalogical] relevance Biochemistry 46 2007 9270 9282
146. K. Jomova, and M. Valko Advances in metal-induced oxidative stress and human disease Toxicology 283 2011 65 87
147. K. Jomova, D. Vondrakova, M. Lawson, and M. Valko Metals, oxidative stress and neurodegenerative disorders Mol. Cell. Biochem. 345 2010 91 104
148. E. Joosten, E. Lesaffre, R. Riezler, V. Ghekiere, L. Dereymaeker, W. Pelemans, and E. Dejaeger Is metabolic evidence for vitamin B-12 and folate deficiency more frequent in elderly patients with Alzheimer's disease? J. Gerontol. A Biol. Sci. Med. Sci. 52 1997 M76 79
149. 2+ ion concentration Angew. Chem. Int. Ed. Engl. 46 2007 3959 3961
150. H. Khosravani, Y. Zhang, S. Tsutsui, S. Hameed, C. Altier, J. Hamid, L. Chen, M. Villemaire, Z. Ali, F.R. Jirik, and G.W. Zamponi Prion protein attenuates excitotoxicity by inhibiting NMDA receptors J. Cell Biol. 181 2008 551 565
151. G.K. Kong, J.J. Adams, H.H. Harris, J.F. Boas, C.C. Curtain, D. Galatis, C.L. Masters, K.J. Barnham, W.J. McKinstry, R. Cappai, and M.W. Parker Structural studies of the Alzheimer's amyloid precursor protein copper-binding domain reveal how it binds copper ions J. Mol. Biol. 367 2007 148 161
152. G.K. Kong, L.A. Miles, G.A. Crespi, C.J. Morton, H.L. Ng, K.J. Barnham, W.J. McKinstry, R. Cappai, and M.W. Parker Copper binding to the Alzheimer's disease amyloid precursor protein Eur. Biophys. J. 37 2008 269 279
153. A. Kontush Amyloid-beta: an antioxidant that becomes a pro-oxidant and critically contributes to Alzheimer's disease Free Radic. Biol. Med. 31 2001 1120 1131
154. A. Koyama, O.I. Okereke, T. Yang, D. Blacker, D.J. Selkoe, and F. Grodstein Plasma amyloid-beta as a predictor of dementia and cognitive decline: a systematic review and meta-analysis Arch. Neurol. 69 2012 824 831
155. Y.M. Kuo, M.R. Emmerling, C. Vigo-Pelfrey, T.C. Kasunic, J.B. Kirkpatrick, G.H. Murdoch, M.J. Ball, and A.E. Roher Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains J. Biol. Chem. 271 1996 4077 4081
156. A. Kurz, and R. Perneczky Amyloid clearance as a treatment target against Alzheimer's disease J. Alzheimers Dis. 24 Suppl 2 2011 61 73
157. F.M. LaFerla Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease Nat. Rev. Neurosci. 3 2002 862 872
158. M.P. Lambert, A.K. Barlow, B.A. Chromy, C. Edwards, R. Freed, M. Liosatos, T.E. Morgan, I. Rozovsky, B. Trommer, K.L. Viola, P. Wals, C. Zhang, C.E. Finch, G.A. Krafft, and W.L. Klein Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins Proc. Natl. Acad. Sci. USA 95 1998 6448 6453
159. L. Lannfelt, K. Blennow, H. Zetterberg, S. Batsman, D. Ames, J. Harrison, C.L. Masters, S. Targum, A.I. Bush, R. Murdoch, J. Wilson, and C.W. Ritchie Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial Lancet Neurol. 7 2008 779 786
160. M.E. Larson, and S.E. Lesne Soluble Abeta oligomer production and toxicity J. Neurochem. 120 Suppl 1 2012 125 139
161. J. Lauren, D.A. Gimbel, H.B. Nygaard, J.W. Gilbert, and S.M. Strittmatter Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers Nature 457 2009 1128 1132
162. J.Y. Lee, E. Cho, J.W. Seo, J.J. Hwang, and J.Y. Koh Alteration of the cerebral zinc pool in a mouse model of Alzheimer disease J. Neuropathol. Exp. Neurol. 71 2012 211 222
163. J.Y. Lee, T.B. Cole, R.D. Palmiter, S.W. Suh, and J.Y. Koh Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice Proc. Natl. Acad. Sci. USA 99 2002 7705 7710
164. J.Y. Lee, I. Mook-Jung, and J.Y. Koh Histochemically reactive zinc in plaques of the Swedish mutant beta-amyloid precursor protein transgenic mice J. Neurosci. 19 1999 RC10 (1-5)
165. P. Lei, S. Ayton, D.I. Finkelstein, L. Spoerri, G.D. Ciccotosto, D.K. Wright, B.X. Wong, P.A. Adlard, R.A. Cherny, L.Q. Lam, B.R. Roberts, I. Volitakis, G.F. Egan, C.A. McLean, R. Cappai, J.A. Duce, and A.I. Bush Tau deficiency induces Parkinsonism with dementia by impairing APP-mediated iron export Nat. Med. 18 2012 291 295
166. S. Leutner, C. Czech, K. Schindowski, N. Touchet, A. Eckert, and W.E. Muller Reduced antioxidant enzyme activity in brains of mice transgenic for human presenilin-1 with single or multiple mutations Neurosci. Lett. 292 2000 87 90
167. Y. Li, C.J. Hough, C.J. Frederickson, and J.M. Sarvey Induction of mossy fiber → Ca3 long-term potentiation requires translocation of synaptically released Zn2+ J. Neurosci. 21 2001 8015 8025
168. S.A. Lipton The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonism Curr. Alzheimer Res. 2 2005 155 165
169. S.A. Lipton Pathologically activated therapeutics for neuroprotection Nat. Rev. Neurosci. 8 2007 803 808
170. S.A. Lipton, Y.B. Choi, Z.H. Pan, S.Z. Lei, H.S. Chen, N.J. Sucher, J. Loscalzo, D.J. Singel, and J.S. Stamler A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds Nature 364 1993 626 632
171. S.A. Lipton, Y.B. Choi, H. Takahashi, D. Zhang, W. Li, A. Godzik, and L.A. Bankston Cysteine regulation of protein function-as exemplified by NMDA-receptor modulation Trends Neurosci. 25 2002 474 480
172. H. Liu, L.E. Harrell, S. Shenvi, T. Hagen, and R.M. Liu Gender differences in glutathione metabolism in Alzheimer's disease J. Neurosci. Res. 79 2005 861 867
173. A. Lleo, S.M. Greenberg, and J.H. Growdon Current pharmacotherapy for Alzheimer's disease Annu. Rev. Med. 57 2006 513 533
174. M.A. Lovell, J.D. Robertson, W.J. Teesdale, J.L. Campbell, and W.R. Markesbery Copper, iron and zinc in Alzheimer's disease senile plaques J. Neurol. Sci. 158 1998 47 52
175. S. Lovestone, and C.H. Reynolds The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes Neuroscience 78 1997 309 324
176. Y.M. Lu, F.A. Taverna, R. Tu, C.A. Ackerley, Y.T. Wang, and J. Roder Endogenous Zn(2+) is required for the induction of long-term potentiation at rat hippocampal mossy fiber-CA3 synapses Synapse 38 2000 187 197
177. J.A. Luchsinger, M.X. Tang, S. Shea, J. Miller, R. Green, and R. Mayeux Plasma homocysteine levels and risk of Alzheimer disease Neurology 62 2004 1972 1976
178. L.F. Lue, Y.M. Kuo, A.E. Roher, L. Brachova, Y. Shen, L. Sue, T. Beach, J.H. Kurth, R.E. Rydel, and J. Rogers Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease Am. J. Pathol. 155 1999 853 862
179. J.W. Lustbader, M. Cirilli, C. Lin, H.W. Xu, K. Takuma, N. Wang, C. Caspersen, X. Chen, S. Pollak, M. Chaney, F. Trinchese, S. Liu, F. Gunn-Moore, L.F. Lue, D.G. Walker, P. Kuppusamy, Z.L. Zewier, O. Arancio, D. Stern, S.S. Yan, and H. Wu ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease Science 304 2004 448 452
180. L.A. MacMillan-Crow, and J.A. Thompson Tyrosine modifications and inactivation of active site manganese superoxide dismutase mutant (Y34F) by peroxynitrite Arch. Biochem. Biophys. 366 1999 82 88
181. M. Manczak, T.S. Anekonda, E. Henson, B.S. Park, J. Quinn, and P.H. Reddy Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression Hum. Mol. Genet. 15 2006 1437 1449
182. P. Mao, M. Manczak, M.J. Calkins, Q. Truong, T.P. Reddy, A.P. Reddy, U. Shirendeb, H.H. Lo, P.S. Rabinovitch, and P.H. Reddy Mitochondria-targeted catalase reduces abnormal APP processing, amyloid beta production and BACE1 in a mouse model of Alzheimer's disease: implications for neuroprotection and lifespan extension Hum Mol Genet. 21 2012 2973 2990
183. D.L. Marcus, C. Thomas, C. Rodriguez, K. Simberkoff, J.S. Tsai, J.A. Strafaci, and M.L. Freedman Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease Exp. Neurol. 150 1998 40 44
184. W.R. Markesbery, and M.A. Lovell Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease Neurobiol. Aging 19 1998 33 36
185. G. Martel, C. Hevi, O. Friebely, T. Baybutt, and G.P. Shumyatsky Zinc transporter 3 is involved in learned fear and extinction, but not in innate fear Learn Mem. 17 2010 582 590
186. S. Martin-Aragon, P. Bermejo-Bescos, J. Benedi, E. Felici, P. Gil, J.M. Ribera, and A.M. Villar Metalloproteinase's activity and oxidative stress in mild cognitive impairment and Alzheimer's disease Neurochem. Res. 34 2009 373 378
187. K. Matsumoto, Y. Akao, H. Yi, M. Shamoto-Nagai, W. Maruyama, and M. Naoi Overexpression of amyloid precursor protein induces susceptibility to oxidative stress in human neuroblastoma SH-SY5Y cells J. Neural Transm. 113 2006 125 135
188. M.P. Mattson, S.L. Chan, and S. Camandola Presenilin mutations and calcium signaling defects in the nervous and immune systems BioEssays 23 2001 733 744
189. I. Maurer, S. Zierz, and H.J. Moller A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients Neurobiol. Aging 21 2000 455 462
190. A. McCaddon, G. Davies, P. Hudson, S. Tandy, and H. Cattell Total serum homocysteine in senile dementia of Alzheimer type Int. J. Geriatr. Psychiatry 13 1998 235 239
191. C.A. McLean, R.A. Cherny, F.W. Fraser, S.J. Fuller, M.J. Smith, K. Beyreuther, A.I. Bush, and C.L. Masters Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease Ann. Neurol. 46 1999 860 866
192. G. Meloni, P. Faller, and M. Vasak Redox silencing of copper in metal-linked neurodegenerative disorders: reaction of Zn7metallothionein-3 with Cu2+ ions J. Biol. Chem. 282 2007 16068 16078
193. G. Meloni, V. Sonois, T. Delaine, L. Guilloreau, A. Gillet, J. Teissie, P. Faller, and M. Vasak Metal swap between Zn7-metallothionein-3 and amyloid-beta-Cu protects against amyloid-beta toxicity Nat. Chem. Biol. 4 2008 366 372
194. L.M. Miller, Q. Wang, T.P. Telivala, R.J. Smith, A. Lanzirotti, and J. Miklossy Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with beta-amyloid deposits in Alzheimer's disease J. Struct. Biol. 155 2006 30 37
195. E.H. Mizrahi, D.W. Jacobsen, S.M. Debanne, F. Traore, A.J. Lerner, R.P. Friedland, and G.J. Petot Plasma total homocysteine levels, dietary vitamin B6 and folate intake in AD and healthy aging J. Nutr. Health Aging 7 2003 160 165
196. J.A. Molina, F.J. Jimenez-Jimenez, M.V. Aguilar, I. Meseguer, C.J. Mateos-Vega, M.J. Gonzalez-Munoz, F. de Bustos, J. Porta, M. Orti-Pareja, M. Zurdo, E. Barrios, and M.C. Martinez-Para Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease J. Neural Transm. 105 1998 479 488
197. S.A. Molloy, and J.H. Kaplan Copper-dependent recycling of hCTR1, the human high affinity copper transporter J. Biol. Chem. 284 2009 29704 29713
198. A.L. Monget, P. Galan, P. Preziosi, H. Keller, C. Bourgeois, J. Arnaud, A. Favier, and S. Hercberg Micronutrient status in elderly people. Geriatrie/Min. Vit. Aux Network Int. J. Vitam. Nutr. Res. 66 1996 71 76
199. H.N. Munro, P.M. Suter, and R.M. Russell Nutritional requirements of the elderly Annu. Rev. Nutr. 7 1987 23 49
200. K. Murakami, N. Murata, Y. Noda, S. Tahara, T. Kaneko, N. Kinoshita, H. Hatsuta, S. Murayama, K.J. Barnham, K. Irie, T. Shirasawa, and T. Shimizu SOD1 (copper/zinc superoxide dismutase) deficiency drives amyloid beta protein oligomerization and memory loss in mouse model of Alzheimer disease J. Biol. Chem. 286 2011 44557 44568
201. T. Nakamura, and S.A. Lipton Redox regulation of mitochondrial fission, protein misfolding, synaptic damage, and neuronal cell death: potential implications for Alzheimer's and Parkinson's diseases Apoptosis 15 2010 1354 1363
202. T. Nakamura, and S.A. Lipton S-nitrosylation of critical protein thiols mediates protein misfolding and mitochondrial dysfunction in neurodegenerative diseases Antioxid. Redox Signal. 14 2011 1479 1492
203. A.S. Nakashima, and R.H. Dyck Dynamic, experience-dependent modulation of synaptic zinc within the excitatory synapses of the mouse barrel cortex Neuroscience 170 2010 1015 1019
204. T.J. Nelson, and D.L. Alkon Oxidation of cholesterol by amyloid precursor protein and beta-amyloid peptide J. Biol. Chem. 280 2005 7377 7387
205. Y. Nose, L.K. Wood, B.E. Kim, J.R. Prohaska, R.S. Fry, J.W. Spears, and D.J. Thiele Ctr1 is an apical copper transporter in mammalian intestinal epithelial cells in vivo that is controlled at the level of protein stability J. Biol. Chem. 285 2010 32385 32392
206. H.G. Oh, Y.S. Chun, Y. Kim, S.H. Youn, S. Shin, M.K. Park, T.W. Kim, and S. Chung Modulation of transient receptor potential melastatin related 7 (TRPM7) channel by presenilins Dev. Neurobiol. 72 2012 865 877
207. C. Opazo, X. Huang, R.A. Cherny, R.D. Moir, A.E. Roher, A.R. White, R. Cappai, C.L. Masters, R.E. Tanzi, N.C. Inestrosa, and A.I. Bush Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2) J. Biol. Chem. 277 2002 40302 40308
208. C. Opazo, S. Luza, V.L. Villemagne, I. Volitakis, C. Rowe, K.J. Barnham, D. Strozyk, C.L. Masters, R.A. Cherny, and A.I. Bush Radioiodinated clioquinol as a biomarker for beta-amyloid: Zn complexes in Alzheimer's disease Aging Cell 5 2006 69 79
209. M. Padurariu, A. Ciobica, L. Hritcu, B. Stoica, W. Bild, and C. Stefanescu Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease Neurosci. Lett. 469 2010 6 10
210. R.D. Palmiter, T.B. Cole, C.J. Quaife, and S.D. Findley ZnT-3, a putative transporter of zinc into synaptic vesicles Proc. Natl. Acad. Sci. USA 93 1996 14934 14939
211. R.D. Palmiter, S.D. Findley, T.E. Whitmore, and D.M. Durnam MT-III, a brain-specific member of the metallothionein gene family Proc. Natl. Acad. Sci. USA 89 1992 6333 6337
212. E. Pan, X.A. Zhang, Z. Huang, A. Krezel, M. Zhao, C.E. Tinberg, S.J. Lippard, and J.O. McNamara Vesicular zinc promotes presynaptic and inhibits postsynaptic long-term potentiation of mossy fiber-CA3 synapse Neuron 71 2011 1116 1126
213. L. Pase, I. Voskoboinik, M. Greenough, and J. Camakaris Copper stimulates trafficking of a distinct pool of the Menkes copper ATPase (ATP7A) to the plasma membrane and diverts it into a rapid recycling pool Biochem. J. 378 2004 1031 1037
214. B.N. Patel, R.J. Dunn, S.Y. Jeong, Q. Zhu, J.P. Julien, and S. David Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury J. Neurosci. 22 2002 6578 6586
215. J.T. Pedersen, C. Hureau, L. Hemmingsen, N.H. Heegaard, J. Ostergaard, M. Vasak, and P. Faller Rapid exchange of metal between Zn(7)-metallothionein-3 and amyloid-beta peptide promotes amyloid-related structural changes Biochemistry 51 2012 1697 1706
216. T.L. Perry, V.W. Yong, C. Bergeron, S. Hansen, and K. Jones Amino acids, glutathione, and glutathione transferase activity in the brains of patients with Alzheimer's disease Ann. Neurol. 21 1987 331 336
217. M.J. Petris, J.F. Mercer, J.G. Culvenor, P. Lockhart, P.A. Gleeson, and J. Camakaris Ligand-regulated transport of the Menkes copper P-type ATPase efflux pump from the Golgi apparatus to the plasma membrane: a novel mechanism of regulated trafficking EMBO J. 15 1996 6084 6095
218. M.J. Petris, K. Smith, J. Lee, and D.J. Thiele Copper-stimulated endocytosis and degradation of the human copper transporter, hCtr1 J. Biol. Chem. 278 2003 9639 9646
219. M.B. Podlisny, B.L. Ostaszewski, S.L. Squazzo, E.H. Koo, R.E. Rydell, D.B. Teplow, and D.J. Selkoe Aggregation of secreted amyloid beta-protein into sodium dodecyl sulfate-stable oligomers in cell culture J. Biol. Chem. 270 1995 9564 9570
220. B.F. Popescu, and H. Nichol Mapping brain metals to evaluate therapies for neurodegenerative disease CNS Neurosci. Ther. 17 2011 256 268
221. S.R. Powell The antioxidant properties of zinc J. Nutr. 130 2000 1447S 1454S
222. D. Pratico, K. Uryu, S. Leight, J.Q. Trojanoswki, and V.M. Lee Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis J. Neurosci. 21 2001 4183 4187
223. K.A. Price, P.J. Crouch, I. Volitakis, B.M. Paterson, S. Lim, P.S. Donnelly, and A.R. White Mechanisms controlling the cellular accumulation of copper bis(thiosemicarbazonato) complexes Inorg. Chem. 50 2011 9594 9605
224. L. Puglielli, A.L. Friedlich, K.D. Setchell, S. Nagano, C. Opazo, R.A. Cherny, K.J. Barnham, J.D. Wade, S. Melov, D.M. Kovacs, and A.I. Bush Alzheimer disease beta-amyloid activity mimics cholesterol oxidase J. Clin. Invest. 115 2005 2556 2563
225. P. Quadri, C. Fragiacomo, R. Pezzati, E. Zanda, G. Forloni, M. Tettamanti, and U. Lucca Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia Am. J. Clin. Nutr. 80 2004 114 122
226. R. Rajendran, R. Minqin, M.D. Ynsa, G. Casadesus, M.A. Smith, G. Perry, B. Halliwell, and F. Watt A novel approach to the identification and quantitative elemental analysis of amyloid deposits-insights into the pathology of Alzheimer's disease Biochem. Biophys. Res. Commun. 382 2009 91 95
227. G. Ravaglia, P. Forti, F. Maioli, B. Nesi, L. Pratelli, L. Savarino, D. Cucinotta, and G. Cavalli Blood micronutrient and thyroid hormone concentrations in the oldest-old J. Clin. Endocrinol. Metab. 85 2000 2260 2265
228. P.H. Reddy, M. Manczak, P. Mao, M.J. Calkins, A.P. Reddy, and U. Shirendeb Amyloid-beta and mitochondria in aging and Alzheimer's disease: implications for synaptic damage and cognitive decline J. Alzheimers Dis. 20 Suppl 2 2010 S499 512
229. P.H. Reddy, S. McWeeney, B.S. Park, M. Manczak, R.V. Gutala, D. Partovi, Y. Jung, V. Yau, R. Searles, M. Mori, and J. Quinn Gene expression profiles of transcripts in amyloid precursor protein transgenic mice. Up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease Hum. Mol. Genet. 13 2004 1225 1240
230. M.R. Reynolds, J.F. Reyes, Y. Fu, E.H. Bigio, A.L. Guillozet-Bongaarts, R.W. Berry, and L.I. Binder Tau nitration occurs at tyrosine 29 in the fibrillar lesions of Alzheimer's disease and other tauopathies J. Neurosci. 26 2006 10636 10645
231. P. Rinaldi, M.C. Polidori, A. Metastasio, E. Mariani, P. Mattioli, A. Cherubini, M. Catani, R. Cecchetti, U. Senin, and P. Mecocci Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease Neurobiol. Aging 24 2003 915 919
232. C.W. Ritchie, A.I. Bush, A. Mackinnon, S. Macfarlane, M. Mastwyk, L. MacGregor, L. Kiers, R. Cherny, Q.X. Li, A. Tammer, D. Carrington, C. Mavros, I. Volitakis, M. Xilinas, D. Ames, S. Davis, K. Beyreuther, R.E. Tanzi, and C.L. Masters Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial Arch. Neurol. 60 2003 1685 1691
233. J.T. Rogers, J.D. Randall, C.M. Cahill, P.S. Eder, X. Huang, H. Gunshin, L. Leiter, J. McPhee, S.S. Sarang, T. Utsuki, N.H. Greig, D.K. Lahiri, R.E. Tanzi, A.I. Bush, T. Giordano, and S.R. Gullans An iron-responsive element type II in the 5′-untranslated region of the Alzheimer's amyloid precursor protein transcript J. Biol. Chem. 277 2002 45518 45528
234. A.E. Roher, K.C. Palmer, E.C. Yurewicz, M.J. Ball, and B.D. Greenberg Morphological and biochemical analyses of amyloid plaque core proteins purified from Alzheimer disease brain tissue J. Neurochem. 61 1993 1916 1926
235. S. Scheuermann, B. Hambsch, L. Hesse, J. Stumm, C. Schmidt, D. Beher, T.A. Bayer, K. Beyreuther, and G. Multhaup Homodimerization of amyloid precursor protein and its implication in the amyloidogenic pathway of Alzheimer's disease J. Biol. Chem. 276 2001 33923 33929
236. M.L. Schlief, A.M. Craig, and J.D. Gitlin NMDA receptor activation mediates copper homeostasis in hippocampal neurons J. Neurosci. 25 2005 239 246
237. M.L. Schlief, and J.D. Gitlin Copper homeostasis in the CNS: a novel link between the NMDA receptor and copper homeostasis in the hippocampus Mol. Neurobiol. 33 2006 81 90
238. M.L. Schlief, T. West, A.M. Craig, D.M. Holtzman, and J.D. Gitlin Role of the Menkes copper-transporting ATPase in NMDA receptor-mediated neuronal toxicity Proc. Natl. Acad. Sci. USA 103 2006 14919 14924
239. C. Schmidt, E. Lepsverdize, S.L. Chi, A.M. Das, S.V. Pizzo, A. Dityatev, and M. Schachner Amyloid precursor protein and amyloid beta-peptide bind to ATP synthase and regulate its activity at the surface of neural cells Mol. Psychiatry 13 2008 953 969
240. M. Schrag, C. Mueller, U. Oyoyo, M.A. Smith, and W.M. Kirsch Iron, zinc and copper in the Alzheimer's disease brain: a quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion Prog. Neurobiol. 94 2011 296 306
241. D.J. Selkoe Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior Behav. Brain Res. 192 2008 106 113
242. M.L. Selley Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer's disease Neurobiol. Aging 24 2003 903 907
243. G.M. Shankar, S. Li, T.H. Mehta, A. Garcia-Munoz, N.E. Shepardson, I. Smith, F.M. Brett, M.A. Farrell, M.J. Rowan, C.A. Lemere, C.M. Regan, D.M. Walsh, B.L. Sabatini, and D.J. Selkoe Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory Nat. Med. 14 2008 837 842
244. M. Sibrian-Vazquez, J.O. Escobedo, S. Lim, G.K. Samoei, and R.M. Strongin Homocystamides promote free-radical and oxidative damage to proteins Proc. Natl. Acad. Sci. USA 107 2010 551 554
245. A. Simons, T. Ruppert, C. Schmidt, A. Schlicksupp, R. Pipkorn, J. Reed, C.L. Masters, A.R. White, R. Cappai, K. Beyreuther, T.A. Bayer, and G. Multhaup Evidence for a copper-binding superfamily of the amyloid precursor protein Biochemistry 41 2002 9310 9320
246. C. Sindreu, R.D. Palmiter, and D.R. Storm Zinc transporter ZnT-3 regulates presynaptic Erk1/2 signaling and hippocampus-dependent memory Proc. Natl. Acad. Sci. USA 108 2011 3366 3370
247. E. Smirnova, L. Griparic, D.L. Shurland, and A.M. van der Bliek Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells Mol. Biol. Cell 12 2001 2245 2256
248. D.G. Smith, R. Cappai, and K.J. Barnham The redox chemistry of the Alzheimer's disease amyloid beta peptide Biochim. Biophys. Acta 1768 2007 1976 1990
249. D.P. Smith, D.G. Smith, C.C. Curtain, J.F. Boas, J.R. Pilbrow, G.D. Ciccotosto, T.L. Lau, D.J. Tew, K. Perez, J.D. Wade, A.I. Bush, S.C. Drew, F. Separovic, C.L. Masters, R. Cappai, and K.J. Barnham Copper-mediated amyloid-beta toxicity is associated with an intermolecular histidine bridge J. Biol. Chem. 281 2006 15145 15154
250. M.A. Smith, G. Perry, P.L. Richey, L.M. Sayre, V.E. Anderson, M.F. Beal, and N. Kowall Oxidative damage in Alzheimer's Nature 382 1996 120 121
251. M.A. Smith, P.L. Richey Harris, L.M. Sayre, J.S. Beckman, and G. Perry Widespread peroxynitrite-mediated damage in Alzheimer's disease J. Neurosci. 17 1997 2653 2657
252. R.S. Sohal, L. Arnold, and W.C. Orr Effect of age on superoxide dismutase, catalase, glutathione reductase, inorganic peroxides, TBA-reactive material, GSH/GSSG, NADPH/NADP+ and NADH/NAD+ in Drosophila melanogaster Mech. Ageing Dev. 56 1990 223 235
253. R. Squitti, D. Lupoi, P. Pasqualetti, G. Dal Forno, F. Vernieri, P. Chiovenda, L. Rossi, M. Cortesi, E. Cassetta, and P.M. Rossini Elevation of serum copper levels in Alzheimer's disease Neurology 59 2002 1153 1161
254. J.S. Stamler, D.I. Simon, J.A. Osborne, M.E. Mullins, O. Jaraki, T. Michel, D.J. Singel, and J. Loscalzo S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds Proc. Natl. Acad. Sci. USA 89 1992 444 448
255. H. Steiner, R. Fluhrer, and C. Haass Intramembrane proteolysis by gamma-secretase J. Biol. Chem. 283 2008 29627 29631
256. F. Stellato, G. Menestrina, M.D. Serra, C. Potrich, R. Tomazzolli, W. Meyer-Klaucke, and S. Morante Metal binding in amyloid beta-peptides shows intra- and inter-peptide coordination modes Eur. Biophys. J. 35 2006 340 351
257. S.J. Stohs, and D. Bagchi Oxidative mechanisms in the toxicity of metal ions Free Radic. Biol. Med. 18 1995 321 336
258. M. Stoltenberg, A.I. Bush, G. Bach, K. Smidt, A. Larsen, J. Rungby, S. Lund, P. Doering, and G. Danscher Amyloid plaques arise from zinc-enriched cortical layers in APP/PS1 transgenic mice and are paradoxically enlarged with dietary zinc deficiency Neuroscience 150 2007 357 369
259. S.W. Suh, K.B. Jensen, M.S. Jensen, D.S. Silva, P.J. Kesslak, G. Danscher, and C.J. Frederickson Histochemically-reactive zinc in amyloid plaques, angiopathy, and degenerating neurons of Alzheimer's diseased brains Brain Res. 852 2000 274 278
260. R. Sultana, D. Boyd-Kimball, H.F. Poon, J. Cai, W.M. Pierce, J.B. Klein, M. Merchant, W.R. Markesbery, and D.A. Butterfield Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD Neurobiol. Aging 27 2006 1564 1576
261. C.D. Syme, and J.H. Viles Solution 1H NMR investigation of Zn2+ and Cd2+ binding to amyloid-beta peptide (Abeta) of Alzheimer's disease Biochim. Biophys. Acta 1764 2006 246 256
262. B.J. Tabner, S. Turnbull, O.M. El-Agnaf, and D. Allsop Formation of hydrogen peroxide and hydroxyl radicals from A(beta) and alpha-synuclein as a possible mechanism of cell death in Alzheimer's disease and Parkinson's disease Free Radic. Biol. Med. 32 2002 1076 1083
263. L. Tapia, M. Gonzalez-Aguero, M.F. Cisternas, M. Suazo, V. Cambiazo, R. Uauy, and M. Gonzalez Metallothionein is crucial for safe intracellular copper storage and cell survival at normal and supra-physiological exposure levels Biochem. J. 378 2004 617 624
264. D.F. Tardiff, M.L. Tucci, K.A. Caldwell, G.A. Caldwell, and S. Lindquist Different 8-hydroxyquinolines protect models of TDP-43 protein, alpha-synuclein, and polyglutamine proteotoxicity through distinct mechanisms J. Biol. Chem. 287 2012 4107 4120
265. S. Toriumi, T. Saito, T. Hosokawa, Y. Takahashi, T. Numata, and M. Kurasaki Metal binding ability of metallothionein-3 expressed in Escherichia coli Basic Clin. Pharmacol. Toxicol. 96 2005 295 301
266. L.L. Torres, N.B. Quaglio, G.T. de Souza, R.T. Garcia, L.M. Dati, W.L. Moreira, A.P. Loureiro, J.N. de Souza-Talarico, J. Smid, C.S. Porto, C.M. Bottino, R. Nitrini, S.B. Barros, R. Camarini, and T. Marcourakis Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer's disease J. Alzheimers Dis. 26 2011 59 68
267. V. Tougu, A. Karafin, and P. Palumaa Binding of zinc(II) and copper(II) to the full-length Alzheimer's amyloid-beta peptide J. Neurochem. 104 2008 1249 1259
268. J.Q. Trojanowski, H. Vandeerstichele, M. Korecka, C.M. Clark, P.S. Aisen, R.C. Petersen, K. Blennow, H. Soares, A. Simon, P. Lewczuk, R. Dean, E. Siemers, W.Z. Potter, M.W. Weiner, C.R. Jack Jr., W. Jagust, A.W. Toga, V.M. Lee, and L.M. Shaw Update on the biomarker core of the Alzheimer's disease Neuroimaging Initiative subjects Alzheimers Dement 6 2010 230 238
269. S. Tsuji, H. Kobayashi, Y. Uchida, Y. Ihara, and T. Miyatake Molecular cloning of human growth inhibitory factor cDNA and its down-regulation in Alzheimer's disease EMBO J. 11 1992 4843 4850
270. Y. Uchida, F. Gomi, T. Masumizu, and Y. Miura Growth inhibitory factor prevents neurite extension and the death of cortical neurons caused by high oxygen exposure through hydroxyl radical scavenging J. Biol. Chem. 277 2002 32353 32359
271. Y. Uchida, K. Takio, K. Titani, Y. Ihara, and M. Tomonaga The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein Neuron 7 1991 337 347
272. D. Valensin, F.M. Mancini, M. Luczkowski, A. Janicka, K. Wisniewska, E. Gaggelli, G. Valensin, L. Lankiewicz, and H. Kozlowski Identification of a novel high affinity copper binding site in the APP(145-155) fragment of amyloid precursor protein Dalton Trans. 1 2004 16 22
273. D.L. van de Hoef, J. Hughes, I. Livne-Bar, D. Garza, M. Konsolaki, and G.L. Boulianne Identifying genes that interact with Drosophila presenilin and amyloid precursor protein Genesis 47 2009 246 260
274. S. Varadarajan, J. Kanski, M. Aksenova, C. Lauderback, and D.A. Butterfield Different mechanisms of oxidative stress and neurotoxicity for Alzheimer's A beta(1-42) and A beta(25-35) J. Am. Chem. Soc. 123 2001 5625 5631
275. S. Varadarajan, S. Yatin, J. Kanski, F. Jahanshahi, and D.A. Butterfield Methionine residue 35 is important in amyloid beta-peptide-associated free radical oxidative stress Brain Res. Bull. 50 1999 133 141
276. M. Vasak, and D.W. Hasler Metallothioneins: new functional and structural insights Curr. Opin. Chem. Biol. 4 2000 177 183
277. V. Vassiliev, Z.L. Harris, and P. Zatta Ceruloplasmin in neurodegenerative diseases Brain Res. Brain Res. Rev. 49 2005 633 640
278. A. Venti, T. Giordano, P. Eder, A.I. Bush, D.K. Lahiri, N.H. Greig, and J.T. Rogers The integrated role of desferrioxamine and phenserine targeted to an iron-responsive element in the APP-mRNA 5′-untranslated region Ann. NY Acad. Sci. 1035 2004 34 48
279. J. Vina, A. Lloret, R. Orti, and D. Alonso Molecular bases of the treatment of Alzheimer's disease with antioxidants: prevention of oxidative stress Mol. Aspects Med. 25 2004 117 123
280. Y. Wang, V. Hodgkinson, S. Zhu, G.A. Weisman, and M.J. Petris Advances in the understanding of mammalian copper transporters Adv. Nutr. 2 2011 129 137
281. Y.J. Wang, H.D. Zhou, and X.F. Zhou Clearance of amyloid-beta in Alzheimer's disease: progress, problems and perspectives Drug Discov. Today 11 2006 931 938
282. M.W. Weiner, D.P. Veitch, P.S. Aisen, L.A. Beckett, N.J. Cairns, R.C. Green, D. Harvey, C.R. Jack, W. Jagust, E. Liu, J.C. Morris, R.C. Petersen, A.J. Saykin, M.E. Schmidt, L. Shaw, J.A. Siuciak, H. Soares, A.W. Toga, and J.Q. Trojanowski The Alzheimer's disease Neuroimaging Initiative: a review of papers published since its inception Alzheimers Dement 8 2012 S1 68
283. A.R. White, T. Du, K.M. Laughton, I. Volitakis, R.A. Sharples, M.E. Xilinas, D.E. Hoke, R.M. Holsinger, G. Evin, R.A. Cherny, A.F. Hill, K.J. Barnham, Q.X. Li, A.I. Bush, and C.L. Masters Degradation of the Alzheimer disease amyloid beta-peptide by metal-dependent up-regulation of metalloprotease activity J. Biol. Chem. 281 2006 17670 17680
284. A.R. White, X. Huang, M.F. Jobling, C.J. Barrow, K. Beyreuther, C.L. Masters, A.I. Bush, and R. Cappai Homocysteine potentiates copper- and amyloid beta peptide-mediated toxicity in primary neuronal cultures: possible risk factors in the Alzheimer's-type neurodegenerative pathways J. Neurochem. 76 2001 1509 1520
285. A.R. White, G. Multhaup, F. Maher, S. Bellingham, J. Camakaris, H. Zheng, A.I. Bush, K. Beyreuther, C.L. Masters, and R. Cappai The Alzheimer's disease amyloid precursor protein modulates copper-induced toxicity and oxidative stress in primary neuronal cultures J. Neurosci. 19 1999 9170 9179
286. J.S. Whitson, C.G. Glabe, E. Shintani, A. Abcar, and C.W. Cotman Beta-amyloid protein promotes neuritic branching in hippocampal cultures Neurosci. Lett. 110 1990 319 324
287. J.S. Whitson, D.J. Selkoe, and C.W. Cotman Amyloid beta protein enhances the survival of hippocampal neurons in vitro Science 243 1989 1488 1490
288. T.I. Williams, B.C. Lynn, W.R. Markesbery, and M.A. Lovell Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in mild cognitive impairment and early Alzheimer's disease Neurobiol. Aging 27 2006 1094 1099
289. B.A. Yankner, L.K. Duffy, and D.A. Kirschner Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides Science 250 1990 279 282
290. J. Yao, S.S. Petanceska, T.J. Montine, D.M. Holtzman, S.D. Schmidt, C.A. Parker, M.J. Callahan, W.J. Lipinski, C.L. Bisgaier, B.A. Turner, R.A. Nixon, R.N. Martins, C. Ouimet, J.D. Smith, P. Davies, E. Laska, M.E. Ehrlich, L.C. Walker, P.M. Mathews, and S. Gandy Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits J. Neurochem. 90 2004 1011 1018
291. S. Yoshikawa, K. Muramoto, and K. Shinzawa-Itoh Proton-pumping mechanism of cytochrome C oxidase Annu. Rev. Biophys. 40 2011 205 223
292. N. Yoshimoto, M. Tasaki, T. Shimanouchi, H. Umakoshi, and R. Kuboi Oxidation of cholesterol catalyzed by amyloid beta-peptide (Abeta)-Cu complex on lipid membrane J. Biosci. Bioeng. 100 2005 455 459
293. H. You, S. Tsutsui, S. Hameed, T.J. Kannanayakal, L. Chen, P. Xia, J.D. Engbers, S.A. Lipton, P.K. Stys, and G.W. Zamponi Abeta neurotoxicity depends on interactions between copper ions, prion protein, and N-methyl-d-aspartate receptors Proc. Natl. Acad. Sci. USA 109 2012 1737 1742
294. W.H. Yu, W.J. Lukiw, C. Bergeron, H.B. Niznik, and P.E. Fraser Metallothionein III is reduced in Alzheimer's disease Brain Res. 894 2001 37 45
295. P. Zafrilla, J. Mulero, J.M. Xandri, E. Santo, G. Caravaca, and J.M. Morillas Oxidative stress in Alzheimer patients in different stages of the disease Curr. Med. Chem. 13 2006 1075 1083
296. P. Zambenedetti, R. Giordano, and P. Zatta Metallothioneins are highly expressed in astrocytes and microcapillaries in Alzheimer's disease J. Chem. Neuroanat. 15 1998 21 26
297. W. Zheng, and A.D. Monnot Regulation of brain iron and copper homeostasis by brain barrier systems: implication in neurodegenerative diseases Pharmacol. Ther. 133 2012 177 188